NEW YORK, April 17, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Colony NorthStar, Inc. ("Colony NorthStar") (NYSE:CLNS) between February 28, 2017 and March 1, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information go to:
http://www.zlk.com/pslra-d/colony-northstar-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Colony NorthStar’s Healthcare and Investment Management segments were performing worse than reported; (2) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Colony NorthStar you have until June 5, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


How Marco Pharma International Preserves German Homeopathic Traditions in America
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease 



